Varex Imaging Corporation (VREX) |
|
17.94 0.5 (2.87%)
|
03-24 16:00 |
|
Open: |
17.39 |
Pre. Close: |
17.44 |
|
High:
|
18.02 |
Low:
|
17.31 |
|
Volume:
|
210,375 |
Market Cap:
|
719(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:31:14 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 21.7 One year: 25.34 |
| Support: |
Support1: 17.75 Support2: 17.23 |
| Resistance: |
Resistance1: 18.57 Resistance2: 21.7 |
| Pivot: |
17.86  |
| Moving Average: |
MA(5): 17.78 MA(20): 17.87
MA(100): 19.88 MA(250): 20.84 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.4 |
| Stochastic oscillator: |
%K(14,3): 24 %D(3): 32 |
| RSI: |
RSI(14): 46.4 |
| 52-week: |
High: 23.78 Low: 17.23 |
| Average Vol(K): |
3-Month: 322 (K) 10-Days: 337 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VREX ] has closed below upper band by 43.0%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
18.04 - 18.12 |
18.12 - 18.19 |
|
Low:
|
17.13 - 17.21 |
17.21 - 17.29 |
|
Close:
|
17.81 - 17.94 |
17.94 - 18.06 |
|
Company Description |
|
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah. |
Headline News |
Thu, 23 Mar 2023
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer - Stockhead
Sun, 19 Mar 2023
Validea's Top Ten Healthcare Stocks Based On Martin Zweig - 3/19 ... - Nasdaq
Wed, 15 Mar 2023
Federated Hermes Inc. sells its stock in Varex Imaging Co ... - Best Stocks
Fri, 03 Mar 2023
Varex to Present at Two Virtual Investor Conference - Business Wire
Mon, 06 Feb 2023
Jefferies Financial Group Makes a Remark on Varex Imaging Co.'s ... - Best Stocks
Wed, 01 Feb 2023
Varex Imaging Corporation (NASDAQ:VREX) Q1 2023 Earnings Call Transcript - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
40 (M) |
| Shares Float |
40 (M) |
|
% Held by Insiders
|
0.6 (%) |
|
% Held by Institutions
|
113.4 (%) |
|
Shares Short
|
3,570 (K) |
|
Shares Short P.Month
|
3,540 (K) |
Stock Financials |
|
EPS
|
0.8 |
|
EPS Est Next Qtl
|
0.49 |
|
EPS Est This Year
|
1.59 |
|
EPS Est Next Year
|
1.87 |
|
Book Value (p.s.)
|
12.77 |
|
Profit Margin (%)
|
3.6 |
|
Operating Margin (%)
|
10 |
|
Return on Assets (ttm)
|
4.6 |
|
Return on Equity (ttm)
|
6.2 |
|
Qtrly Rev. Growth
|
3.4 |
|
Gross Profit (p.s.)
|
7.06 |
|
Sales Per Share
|
21.6 |
|
EBITDA (p.s.)
|
2.99 |
|
Qtrly Earnings Growth
|
157.6 |
|
Operating Cash Flow
|
2 (M) |
|
Levered Free Cash Flow
|
-35 (M) |
Stock Valuations |
|
PE Ratio
|
22.42 |
|
PEG Ratio
|
3.5 |
|
Price to Book value
|
1.4 |
|
Price to Sales
|
0.83 |
|
Price to Cash Flow
|
299.74 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
